20 Publications
2017
Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia
Kobayashi, MChen, SBai, YYao, CGao, RSun, X-jMu, CTwiggs, TYu, Z-hBoswell, HYoder, MKapur, RMulloy, JZhang, Z-y and Liu, Y
Leukemia, vol. 31, (no. 6), pp. 1453-1457, Jun 2017. | Journal Article
2016
Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-β.
Gade, PadmajaKimball, Amy SDiNardo, Angela CGangwal, PriyamvadaRoss, Douglas DBoswell, H ScottKeay, Susan K and Kalvakolanu, Dhananjaya V
The Journal of biological chemistry, vol. 291, (no. 42), pp. 22030-22042, October 14, 2016. | Journal Article
 
Syk kinase and Shp2 phosphatase inhibition cooperate to reduce FLT3-ITD-induced STAT5 activation and proliferation of acute myeloid leukemia.
Richine, B MVirts, E LBowling, J DRamdas, BMali, RNaoye, RLiu, ZZhang, Z-YBoswell, H SKapur, R and Chan, R J
Leukemia, June 3, 2016. | Journal Article
2014
Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-κB-dependent manner.
Wang, LinWang, LinWang, LinWang, LinZhang, HuajiaZhang, HuajiaZhang, HuajiaZhang, HuajiaRodriguez, SoniaRodriguez, SoniaRodriguez, SoniaRodriguez, SoniaCao, LiyunCao, LiyunCao, LiyunCao, LiyunParish, JonathanParish, JonathanParish, JonathanParish, JonathanMumaw, ChristenMumaw, ChristenMumaw, ChristenMumaw, ChristenZollman, AmyZollman, AmyZollman, AmyZollman, AmyKamoka, Malgorzata M.Kamoka, Malgorzata MKamoka, Malgorzata MKamoka, Malgorzata MMu, JianMu, JianMu, JianMu, JianChen, Danny ZChen, Danny Z.Chen, Danny ZChen, Danny ZSrour, Edward FSrour, Edward F.Srour, Edward FSrour, Edward FChitteti, Brahmananda RChitteti, Brahmananda RChitteti, Brahmananda R.Chitteti, Brahmananda RHogenEsch, HarmHogenEsch, HarmHogenEsch, HarmHogenEsch, HarmTu, XiaolinTu, XiaolinTu, XiaolinTu, XiaolinBellido, Teresita MBellido, Teresita M.Bellido, Teresita MBellido, Teresita MBoswell, H. ScottBoswell, H ScottBoswell, H. ScottBoswell, H. ScottManshouri, TaghiManshouri, TaghiManshouri, TaghiManshouri, TaghiVerstovsek, SrdanVerstovsek, SrdanVerstovsek, SrdanVerstovsek, SrdanYoder, Mervin CYoder, Mervin C.Yoder, Mervin CYoder, Mervin CKapur, ReubenKapur, ReubenKapur, ReubenKapur, ReubenCardoso, Angelo A.Cardoso, Angelo ACardoso, Angelo ACardoso, Angelo ACarlesso, NadiaCarlesso, NadiaCarlesso, Nadia and Carlesso, Nadia
Cell stem cell, vol. 15, (no. 1), pp. 51-65, July 3, 2014. | Journal Article
 
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis.
Chatterjee, AnindyaChatterjee, AnindyaChatterjee, AnindyaGhosh, JoydeepGhosh, JoydeepGhosh, JoydeepRamdas, BaskarRamdas, BaskarRamdas, BaskarMali, Raghuveer SinghMali, Raghuveer SinghMali, Raghuveer SinghMartin, HollyMartin, HollyMartin, HollyKobayashi, MichihiroKobayashi, MichihiroKobayashi, MichihiroVemula, SasidharVemula, SasidharVemula, SasidharCanela, Victor HCanela, Victor HCanela, Victor HWaskow, Emily RWaskow, Emily RWaskow, Emily RVisconte, ValeriaVisconte, ValeriaVisconte, ValeriaTiu, Ramon VTiu, Ramon VTiu, Ramon VSmith, Catherine CSmith, Catherine CSmith, Catherine CShah, NeilShah, NeilShah, NeilBunting, Kevin DBunting, Kevin DBunting, Kevin DBoswell, H ScottBoswell, H. ScottBoswell, H. ScottLiu, YanLiu, YanLiu, YanChan, Rebecca JChan, Rebecca JChan, Rebecca JKapur, ReubenKapur, Reuben and Kapur, Reuben
Cell reports, vol. 9, (no. 4), pp. 1333-1348, November 20, 2014. | Journal Article
2013
The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo.
Nabinger, S CLi, X JRamdas, BHe, YZhang, XZeng, LRichine, BBowling, J DFukuda, SGoenka, SLiu, ZFeng, G-SYu, MenggangSandusky, G EBoswell, H. SZhang, Z-YKapur, Reuben and Chan, R J
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, vol. 27, (no. 2), pp. 398-408, 2013/Feb. | Journal Article
2012
A noncanonical Flt3ITD/NF-κB signaling pathway represses DAPK1 in acute myeloid leukemia.
Shanmugam, RajasubramaniamGade, PadmajaWilson-Weekes, AnniqueSayar, HamidSuvannasankha, AttayaGoswami, ChirayuLi, LangGupta, SushilCardoso, Angelo AAl Baghdadi, TareqSargent, Katie JCripe, Larry DKalvakolanu, Dhananjaya V and Boswell, H S
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 18, (no. 2), pp. 360-9, 2012/Jan/15. | Journal Article
 
Novel combination treatments targeting chronic myeloid leukemia stem cells.
Al Baghdadi, TareqAbonour, Rafat and Boswell, H. S
Clinical lymphoma, myeloma & leukemia, vol. 12, (no. 2), pp. 94-105, 2012/Apr. | Journal Article
2011
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL.
Mali, Raghuveer SMali, Raghuveer SinghRamdas, BaskarRamdas, BaskarMa, PeilinMa, PeilinShi, JianjianShi, JianjianMunugalavadla, VeerendraMunugalavadla, VeerendraSims, EmilySims, EmilyWei, LeiWei, LeiVemula, SasidharVemula, SasidharNabinger, Sarah CNabinger, Sarah CGoodwin, Charles BGoodwin, Charles BChan, RebeccaChan, Rebecca JTraina, FabiolaTraina, FabiolaVisconte, ValeriaVisconte, ValeriaTiu, Ramon VTiu, Ramon VLewis, Timothy ALewis, Timothy AStern, Andrew MStern, Andrew MWen, Qiang JWen, QiangCrispino, John DCrispino, JohnBoswell, H. ScottBoswell, H. SKapur, Reuben and Kapur, Reuben
Cancer cell, vol. 20, (no. 3), pp. 357-69, 2011/Sep/13. | Journal Article
2009
Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3.
Fukuda, SeijiSingh, PratibhaMoh, AkiraAbe, MarikoConway, Edward MBoswell, H SYamaguchi, SeijiFu, Xin Y and Pelus, Louis M
Blood, vol. 114, (no. 2), pp. 394-403, 2009/Jul/9. | Journal Article
2007
MOZ and MOZ-CBP Cooperate with NFκB To Induce Expression of NFκB-Dependent Genes
Chan, Edward MChan, Edward MChan, Rebecca JChan, Rebecca JComer, Elisha MComer, Elisha MGoulet, Robert JGoulet, Robert JCrean, Colin DCrean, Colin DBrown, Zachary DBrown, Zachary DFruehwald, Amy MFruehwald, Amy MYang, ZhenyunYang, ZhenyunBoswell, Howard SBoswell, Howard SNakshatri, HarikrishnaNakshatri, HarikrishnaGabig, Theodore G and Gabig, Theodore G
Blood, vol. 110, (no. 11), pp. 887, 2007-11-16. | Journal Article
2006
Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.
Hartman, Amy DWilson-Weekes, AnniqueSuvannasankha, AttayaBurgess, Gem SPhillips, Carissa AHincher, Katie JCripe, Larry D and Boswell, H Scott
Experimental hematology, vol. 34, (no. 10), pp. 1360-1376, October 2006. | Journal Article
2002
P21waf-1-Chk1 pathway monitors G1 phase microtubule integrity and is crucial for restriction point transition.
Mantel, Charlie RGelfano, Vasily MKim, Young-JuneMcDaniel, AndrewLee, YoungheeBoswell, H S and Broxmeyer, Hal E
Cell cycle (Georgetown, Tex.) , vol. 1, (no. 5), pp. 327-36, 2002 Sep-Oct. | Journal Article
1994
Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
Tauchi, TBoswell, H SLeibowitz, D and Broxmeyer, H E
The Journal of experimental medicine, vol. 179, (no. 1), pp. 167-175, January 1, 1994. | Journal Article
1991
Expression of val-12 mutant ras p21 in an IL-3-dependent murine myeloid cell line is associated with loss of serum-dependence and increases in membrane PIP2-specific phospholipase C activity.
Rizzo, M TBoswell, H SEnglish, D and Gabig, T G
Cellular signalling, vol. 3, (no. 4), pp. 311-319, 1991. | Journal Article
1990
A novel mast cell growth factor (MCGF-3) produced by marrow-adherent cells that synergizes with interleukin 3 and interleukin 4.
Boswell, H. SMochizuki, D YBurgess, G SGillis, SWalker, E BAnderson, D and Williams, D E
Experimental Hematology, vol. 18, (no. 7), pp. 794-800, 1990/Aug. | Journal Article
 
A RAS oncogene imparts growth factor independence to myeloid cells that abnormally regulate protein kinase C: a nonautocrine transformation pathway.
Boswell, H. SNahreini, T SBurgess, G SSrivastava, AGabig, T GInhorn, LSrour, E F and Harrington, M A
Experimental Hematology, vol. 18, (no. 5), pp. 452-60, 1990/Jun. | Journal Article
1989
A mutant RAS gene acts through protein kinase C to augment interleukin-3 dependent proliferation in a fastidious immortal myeloid cell line.
Boswell, H. SHarrington, M ABurgess, G SNahreini, T LDerigs, H GHodges, T DEnglish, DCrean, C D and Gabig, T G
Leukemia, vol. 3, (no. 9), pp. 662-8, 1989/Sep. | Journal Article
1987
A variant t(X;15)(p11;q22) translocation in acute promyelocytic leukemia.
Srivastava, ArunHeerema, NLauer, R CNahreini, PBoswell, H SHoffman, R and Antony, A C
Cancer Genetics and Cytogenetics, vol. 29, (no. 1), pp. 65-74, 1987/Nov. | Journal Article
 
Cellular control of in vitro progression of murine myeloid leukemia: progression accompanies acquisition of independence from growth factor and stromal cells.
Boswell, H. SSrivastava, ABurgess, J SNahreini, PHeerema, NInhorn, LPadgett, FWalker, E B and Geib, R W
Leukemia, vol. 1, (no. 11), pp. 765-71, 1987/Nov. | Journal Article